All stocks / CUBT
Curative Biotechnology Inc CUBT
Curative Biotechnology (CUBT): no warning signs from our rules in the last 12 months. Each fact links to its SEC filing.
OTCIDFlorida, USA
Market listing
- Full name
- CURATIVE BIOTECHNOLOGY INC
- Market tier
- OTC Pink Current
- Trading status
- Active
- Last trade
- Nov 16
News headlines
Curative Biotechnology, Inc. Issues Letter to Shareholders
2026-09-11 07:00 · News Release
Curative Biotechnology Announces U.S. Patent Allowance Strengthening Core Ophthalmology Platform
2026-07-16 07:00 · News Release
Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement
2026-05-07 07:00 · News Release
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy
2026-04-15 08:08 · News Release
Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting
2026-03-23 19:05 · News Release
Curative Biotechnology Announces Canadian Patent Allowance
2026-01-23 08:45 · News Release
Curative Biotechnology, Inc. Announces Letter to Shareholders
Headlines only, with links to the full item. Company press releases are written by the company. 2025-11-18 08:15 · News Release
Signals
No warning signs found in the last 12 months of SEC records. That is not a clean bill of health; it only means none of our rules fired.
Price chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
| 2025-12-22 | RW | RW |
Common questions about CUBT
Does CUBT file reports with the SEC?
Yes. Curative Biotechnology files with the SEC under company number 0001400271. The most recent filing we hold is a RW dated 2025-12-22.
Source recordHas CUBT filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.